Health
Economic burden of acute myeloid leukemia treatment | JBM – Dove Medical Press
What does the economic burden of acute myeloid leukemia treatment look like for the next decade? An analysis of key findings, challenges and recommendations
AML: A Rare and Costly Cancer
Acute myeloid leukemia (AML) arises in the bone marrow from the abnormal clonal expansion of myeloid blood cell precursors. Leukemic blast cells are found in the circulating blood as well as in the bone marrow, where they disrupt normal blood cell production, leading to myelosuppression.1 Consequences of AML include anemia, with weakness and pallor, thrombocytopenia, resulting in bleeding, and leukopenia, leading to fever and infection.
AML, which accounts for about…
-
Noosa News21 hours agoWoman was watching keepers work when lion attacked, Darling Downs Zoo says
-
Noosa News20 hours agoWorking for someone else made it hard to care for my daughter. So I quit
-
General24 hours agoDeveloper warns wind energy capacity may not be ready by WA coal deadline
-
Business6 hours agoFord CEO makes stunning prediction about artificial intelligence